- VISITING ASSOCIATE PROFESSOR Psychiatry
M.D., Florence University
Florence School of Medicine
Florence School of Medicine
Dr. Pallanti's clinical interests include:
Obsessive-compulsive spectrum disorders
Pathological Gambling and Behavioral Addiction
Fax: 0039 55 581051
ResearchDr. Pallanti's primary research interests are pathological gambling, behavioral addiction, and related disorders - including bipolar mood disorders, obsessive compulsive disorder (OCD), and anxiety - with particular attention to the comorbidity with psychosis. As he has documented in recent and past publications, his investigations are related to the clinical and treatment features (including Clinical trials) as well as to the physiopathology and neuroimaging levels of these conditions.
Dr. Pallanti's role within the Department of Psychiatry has included organizing and directing Mount Sinai's Center of Excellence for OCD, impulsive, and behavioral addiction. Under his leadership as Director, the Center continues to break new ground with its cutting-edge approaches to treatment and an innovative blend of therapeutic programs, research, and educational activities.
Pallanti S, Bernardi S, Allen A, Chaplin W, Watner D, DeCaria CM, Hollander E. Noradrenergic Function in Pathological Gambling: Blunted Growth Hormone Response to Clonidine. J of Psychopahrmacogly;: in press.
Pallanti S, Hollander E. Obsessive-Compulsive Disorders Spectrum as a Scientific ''Metaphor''. CNS Spectrum; 13(9): in press.
Pallanti S. Successful duloxetine treatment of a binge-eating disorder: a case report. Journal of Psychopharmacology ;: in press.
Hollander E, Buchsbaum MS, Mehmet Haznedar M, Berenguer J, Berlin H, Chaplin W, Goodman CR, LiCalzi EM, Newmark R, Pallanti S. FDG-PET Study in Pathological Gamblers. Neuropsychobiology; 205: in press.
Pallanti S. Brain plasticity and brain stimulation in neuropsychiatry: toward individualized medicine. CNS Spectr 2008 Apr; 13(4): 287-292.
Pallanti S, Masetti S, Bernardi S, Innocenti A, Markella M, Hollander E. Obsessive compulsive disorder comorbidity in DBA. Clin Pract Epidemol Ment Health 2008 Mar; 10(4): 6.
Pallanti S. Transcultural observations of obsessive-compulsive disorder. Am J Psychiatry 2008 Feb; 165(2): 169-170.
Pallanti S, Masetti S, Bernardi S, Innocenti A, Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ. Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder. Int Clin Psychopharmacol 2007 Nov; 22(6): 313-322.
La Malfa G, Lassi S, Bertelli M, Pallanti S, Albertini G. Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability: The use of Conners' Adult ADHD Rating Scales (CAARS. Res Dev Disabil 2007 Apr 6;.
Hollander E, Kim S, Khanna S, Pallanti S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr 2007 Feb; 12(2 Suppl 3): 5-13.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Pallanti is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Istituto di Neuroscienze
Viale U. Bassi, 1
Florence ITALY, -- 50137